(Q77787475)
Statements
Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin (English)
Marinaro M
Boyaka PN
Jackson RJ
Finkelman FD
Kiyono H
Jirillo E
scientific article published on 01 January 1999